Skip to main content

Quoin Pharmaceuticals, Ltd. (QNRX)

NASDAQ: QNRX · IEX Real-Time Price · USD
3.23
-0.43 (-11.75%)
At close: Dec 3, 2021 4:00 PM
3.59
0.36 (11.15%)
After-hours:Dec 3, 2021 7:41 PM EST
Market Cap26.96M
Revenue (ttm)n/a
Net Income (ttm)-5.10M
Shares Out8.35M
EPS (ttm)-4.92
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume31,316
Open3.66
Previous Close3.66
Day's Range3.22 - 3.66
52-Week Range3.22 - 35.52
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About QNRX

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. It offers QRX003, a potential therapy for the treatment of Netherton Syndrome; QRX004, a topical lotion for the treatment recessive dystrophic epidermolysis bullosa; and QRX006, a topical lotion to treat rare skin disease. The company was founded in 2018 and is based in Ashburn, Virginia.

IndustryBiotechnology
Founded2018
Employees2
Stock ExchangeNASDAQ
Ticker SymbolQNRX
Full Company Profile

Financial Performance

Financial numbers in millions ILSFinancial Statements

News

Quoin Pharmaceuticals Poised for Rapid Commercialization of Promising Pipeline

New York, New York--(Newsfile Corp. - November 16, 2021) - PCG Digital -- Following a successful merger, one firm is developing and commercializing therapies for rare skin conditions. Quoin Pharmaceutic...

2 weeks ago - Newsfile Corp

Quoin Pharmaceuticals and Genpharm Services Sign Exclusive License and Distribution Agreement for Quoin's Lead Asset,...

ASHBURN, Va., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, and Genpharm...

3 weeks ago - GlobeNewsWire

Quoin Pharmaceuticals Signs Exclusive Licensing and Distribution Agreement with AFT Pharmaceuticals for its Lead Asse...

AFT Gains Exclusive Rights to Commercialize QRX003 in Australia and New Zealand

3 weeks ago - GlobeNewsWire

Quoin Pharmaceuticals Appoints Gordon Dunn as Chief Financial Officer

ASHBURN, Va., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, today announ...

1 month ago - GlobeNewsWire

Quoin Pharmaceuticals Completes Merger and Will Commence Trading on Nasdaq Capital Market under Ticker Symbol “QNRX”

Concomitant Investment from Altium Capital Secured Concomitant Investment from Altium Capital Secured

1 month ago - GlobeNewsWire

Cellect Biotechnology Announces Record Date and Distribution Date for CVRs in Connection with Strategic Merger with Q...

Tel Aviv , Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”) (the “Company”), announced today the record date and distribution date for the contingent value rights (the “CVRs...

1 month ago - GlobeNewsWire

5 Short Squeeze Candidates To Watch: Aterian, Marin On List Again, Plus 3 New Small-Cap Medical Plays

Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp (NYSE: GME) and AMC Entertainment Holdings Inc (NYSE: AMC), two stocks that attracted s...

Other symbols:ATERBMRAMRINPROG
2 months ago - Benzinga

Why Cellect Biotechnology Shares Are Rising Today

Cellect Biotechnology Ltd (NASDAQ: APOP) is trading higher Monday after the company announced shareholder approval of the strategic merger with Quoin Pharmaceuticals. Approximately 99% of the votes were...

2 months ago - Benzinga

Here's why Cellect Biotechnology shares are up 50% on Monday

Cellect Biotechnology Ltd (NASDAQ: APOP) shareholders approved the previously announced strategic merger agreement with Quoin Pharmaceuticals, the company said in a press release on Monday. Shares of th...

2 months ago - Invezz

Cellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin Pharmaceuticals

Tel Aviv, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), announced shareholders voted to approve the previously announced strategic merger agreement with privately-held ...

2 months ago - GlobeNewsWire

See Why Cellect Biotechnology Stock Is Soaring During Premarket Friday

Cellect Biotechnology Ltd (NASDAQ: APOP) announced the first ApoGraft transplantation in a Leukemia patient in a clinical trial in the U.S.  ApoGraft is designed to prevent graft-versus-host disease (GV...

3 months ago - Benzinga

Cellect Biotechnology Announces the ApoGraft™ Bone Marrow Transplantation of First Patient in U.S.

Recruitment of Patient Provides Momentum to Commence Funding for the Technology under US Entity EnCellX Recruitment of Patient Provides Momentum to Commence Funding for the Technology under US Entity En...

3 months ago - GlobeNewsWire

Cellect Biotechnology Reports Second Quarter 2021 Financial and Operating Results

Strategic Merger Transaction Remains on Track to Close During the 2021 Third Quarter

3 months ago - GlobeNewsWire

The Securities and Exchange Commission Declared Cellect Biotechnology's Registration Statement Filed on Form F-4 Effe...

Special General Meeting of Shareholders Scheduled for September 19, 2021

3 months ago - GlobeNewsWire

Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist

Biotech penny stocks are in focus; here's 4 to watch right now The post Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist appeared first on Penny Stocks to Buy, Picks, News and Informa...

Other symbols:ACSTCHEKSEELWORX
4 months ago - PennyStocks

Short Squeeze Stocks: CLOV, AEI and 3 Other Stocks Experts Think Are Ready to Pop

Short squeeze stocks have been targeted quite a bit lately as retail traders tackle them in an effort to push out hedge funds. The post Short Squeeze Stocks: CLOV, AEI and 3 Other Stocks Experts Think A...

Other symbols:AEICLOVDBGIORPH
5 months ago - InvestorPlace

These Penny Stocks Are Up Big Today, Worth It or Not?

3 big gaining penny stocks today; are they worth it? The post These Penny Stocks Are Up Big Today, Worth It or Not?

Other symbols:EVFMJFU
5 months ago - PennyStocks

Why Are Cellect Biotechnology (APOP) Shares Surging Today?

Cellect Biotechnology Ltd (NASDAQ: APOP) has filed a registration statement with the SEC in connection with its proposed strategic merger with privately-held Quoin Pharmaceuticals Inc. See the SEC regis...

5 months ago - Benzinga

Cellect Biotechnology Files Registration Statement in Connection with Proposed Strategic Merger Agreement with Quoin ...

Transaction Expected to Close in the 2021 Third Quarter Transaction Expected to Close in the 2021 Third Quarter

5 months ago - GlobeNewsWire

Are These Penny Stocks The Biggest Morning Movers?

These penny stocks moved in early morning trading; will you add them to your watchlist? The post Are These Penny Stocks The Biggest Morning Movers?

Other symbols:BORREYES
6 months ago - PennyStocks

5 Hot Penny Stocks To Buy? Check These Out For May 2021

Looking for the best penny stocks in May 2021? Check these 5 out The post 5 Hot Penny Stocks To Buy?

Other symbols:ATOSEVFMXXII
6 months ago - PennyStocks

Market Update: The 10 Most Volatile Stocks Today

Joins us as we take a look at the most volatile stocks for Monday as many shares see their prices fluctuate during the day. The post Market Update: The 10 Most Volatile Stocks Today appeared first on In...

6 months ago - InvestorPlace

Cellect Bio's ApoGraft Therapy Is Safe, Tolerable In GvHD Study

Cellect Biotechnology Ltd (NASDAQ: APOP) has announced data from the Phase 1/2 study in Israel evaluating ApoGraft technology for Graft versus Host Disease (GvHD), a severe complication of allogeneic he...

7 months ago - Benzinga

Cellect Biotechnology Reports Fourth Quarter and Full Year 2020 Financial and Operating Results

TEL AVIV, Israel, March 29, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”), a developer of innovative technology that enables the functional selection of stem cells, today reported...

8 months ago - GlobeNewsWire

Why Cellect, Immutep, F-star, ProQR and Evofem Are Moving Thursday

Cellect Biotechnology Ltd. (NASDAQ: APOP), Immutep Limited (NASDAQ: IMMP), F-star Therapeutics, Inc. (NASDAQ: FSTX), ProQR Therapeutics N.V.

Other symbols:EVFMFSTXIMMPPRQR
8 months ago - Benzinga